Soumen Khatua Selected Research

Soumen Khatua Research Topics

Disease

34	Neoplasms (Cancer) 08/2023 - 03/2008
12	Medulloblastoma 07/2023 - 06/2013
11	Brain Neoplasms (Brain Tumor) 08/2023 - 07/2005
8	Glioma (Gliomas) 02/2024 - 09/2011
7	Germinoma 01/2022 - 04/2010
6	Diffuse Intrinsic Pontine Glioma 03/2022 - 01/2014
4	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2022 - 07/2010
4	Ependymoma 01/2020 - 09/2015
2	Teratoma (Teratoid Tumor) 11/2022 - 07/2010
2	Pinealoma (Pineoblastoma) 01/2022 - 12/2010
2	Neoplasm Metastasis (Metastasis) 07/2021 - 01/2021
2	Thrombocytopenia (Thrombopenia) 01/2021 - 11/2004
2	Astrocytoma (Pilocytic Astrocytoma) 10/2008 - 04/2003
1	Circulating Neoplastic Cells 07/2023
1	Brain Injuries (Brain Injury) 01/2023
1	Vomiting 01/2022
1	Headache (Headaches) 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Dizziness (Lightheadedness) 01/2022
1	Nausea 01/2022
1	Anemia 01/2021
1	Infratentorial Neoplasms (Posterior Fossa Tumors) 01/2021
1	Residual Neoplasm 01/2021
1	Neutropenia 01/2021
1	Febrile Neutropenia 01/2021
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2018
1	Melanoma (Melanoma, Malignant) 01/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018
1	Fatigue 01/2018
1	Exanthema (Rash) 01/2018
1	Optic Nerve Glioma 01/2018
1	Hematologic Neoplasms (Hematological Malignancy) 12/2017
1	Choroid Plexus Carcinoma 05/2015
1	Typical Teratoid Rhabdoid Tumor 12/2014
1	Brain Stem Neoplasms (Brain Stem Tumor) 01/2014
1	Carcinogenesis 07/2012
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2011
1	Disease Progression 09/2011
1	Primitive Neuroectodermal Tumors (PNET) 01/2010
1	Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara) 01/2010

Drug/Important Bio-Agent (IBA)

7	dipinacoline glutamateIBA 02/2024 - 01/2014
4	TIC10 compoundIBA 02/2024 - 10/2019
3	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 07/2010
2	Histones (Histone)IBA 07/2023 - 07/2021
2	Etoposide (VP 16)FDA LinkGeneric 01/2022 - 07/2010
2	VemurafenibIBA 01/2020 - 01/2018
2	Everolimus FDA Link 01/2020 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 09/2018 - 09/2011
2	Proteins (Proteins, Gene)FDA Link 09/2018 - 04/2003
2	DNA (Deoxyribonucleic Acid)IBA 03/2016 - 10/2008
2	ErbB Receptors (EGF Receptor)IBA 10/2012 - 07/2012
1	VimentinIBA 07/2023
1	N-acetylaspartate (N-acetyl aspartate)IBA 03/2022
1	Choline (Choline Chloride)IBA 03/2022
1	CreatinineIBA 03/2022
1	Alanine Transaminase (SGPT)IBA 01/2022
1	Circulating Tumor DNAIBA 01/2022
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 10/2020
1	Dihydrotachysterol (AT 10)IBA 01/2020
1	FluorineIBA 05/2019
1	ChromatinIBA 01/2019
1	RE1-silencing transcription factorIBA 01/2019
1	Immune Checkpoint InhibitorsIBA 09/2018
1	multidrug resistance-associated protein 1IBA 09/2018
1	Thymidylate SynthaseIBA 09/2018
1	TOR Serine-Threonine KinasesIBA 01/2018
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2018
1	Proteasome InhibitorsIBA 12/2017
1	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2017
1	Bortezomib (Velcade)FDA Link 12/2017
1	UbiquitinIBA 12/2017
1	ixazomibIBA 12/2017
1	carfilzomibIBA 12/2017
1	Methotrexate (Mexate)FDA LinkGeneric 10/2015
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 05/2015
1	Protons (Proton)IBA 06/2013
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 07/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2012
1	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 05/2011
1	Tumor Biomarkers (Tumor Markers)IBA 12/2010
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2010
1	Dexamethasone (Maxidex)FDA LinkGeneric 04/2010
1	Insulin (Novolin)FDA Link 10/2008
1	Insulin-Like PeptidesIBA 10/2008
1	DNA Repair EnzymesIBA 10/2008

Therapy/Procedure

26	Therapeutics 02/2024 - 11/2004
14	Drug Therapy (Chemotherapy) 02/2023 - 07/2005
9	Radiotherapy 01/2023 - 01/2010
4	Proton Therapy 07/2017 - 12/2014
3	Re-Irradiation 03/2022 - 05/2014
3	Craniospinal Irradiation 01/2021 - 06/2013
1	Immunotherapy 02/2023
1	Induction Chemotherapy 01/2022
1	Adjuvant Chemotherapy 01/2021
1	Intraventricular Infusions 01/2020
1	Second-Look Surgery 12/2019
1	Drug Tapering 01/2018